Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Robu
Observed names:
M.V. Robu,
Maria ROBU,
Robu Maria
Institutions:
Institutul Oncologic din Republica Moldova,
Nicolae Testemițanu State University of Medicine and Pharmacy
Observed institutions:
Institutul Oncologic din Republica Moldova,
Nicolae Testemițanu State University of Medicine and Pharmacy
ORCID:
0000-0002-3228-7566
Observed ORCID:
0000-0002-3228-7566
OpenAlex ID:
A5086310383
The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
2023
·
Victor Tomacinschii
, Adrian Mosquera Orgueira
, et al.
·
Frontiers in Oncology
·
9
PDF
Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets
2026
·
Victor Tomacinschii
, Andreea Casian
, et al.
·
Current Cancer Drug Targets
·
3
Integrated Model for Predicting Cancer Therapy-Related Cardiac Dysfunction in Non-Hodgkin Lymphoma
2025
·
Daniela Bursacovschi
, Oleg Arnaut
, et al.
·
Biomedicines
·
3
PDF
Clinical application of HALP score in the determination of nodal non-Hodgkin lymphoma prognosis
2023
·
Victor TOMACINSCHII
, Sanda BURUIANA
, et al.
·
Documenta Haematologica - Revista Romana de Hematologie
·
3
PDF
Impact of targeted treatment in non-Hodgkin’s lymphoma with primary lymph node involvement
2021
·
Victor Tomacinschii
, Maria Robu
, et al.
·
The Moldovan Medical Journal
·
2
PDF
Aspectele clinice ale limfoamelor non-Hodgkin cu afectare primară a ganglionilor limfatici periferici la persoanele în etate
2020
·
Maria Robu
, Victor Tomacinschii
, et al.
·
Public Health Economy and Management in Medicine
·
2
"Assessing the quality of life in patients with non-Hodgkin’s lymphoma is a burden or an advantage?"
2020
·
"
, Sanda BURUIANA
, et al.
·
Archives of the Balkan Medical Union
·
2
Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase of blood in patients with lymphosarcoma (non-hodgkin's disease)
2011
·
L.A. Gavriliuc
, I.F. Corcimaru
, et al.
·
Biomeditsinskaya Khimiya
·
2
PDF
Epidemiological data and diagnosis pitfalls in aggressive extranodal non-Hodgkin’s lymphomas: current issues
2022
·
Dumitrita Urescu
, Vasile Musteata
, et al.
·
Moldovan Journal of Health Sciences
·
1
PDF
Clinical patterns and complete blood count parameters in the young patients with primary myelofibrosis in the prefibrotic stage
2022
·
Nina Sghibneva-Bobeico
, Vasile Musteata
, et al.
·
Moldovan Journal of Health Sciences
·
1
PDF
ABCL-306: Clinical Application of HALP Score in the Determination of Nodal Diffuse Large B-Cell Lymphoma Prognosis
2021
·
Victor Tomacinschii
, Sanda Buruiana
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
IBCL-309: The Frequency of Anticardiolipin Antibodies in Patients with Non-Hodgkin Lymphoma
2020
·
Sanda Buruiana
, Minodora Mazur
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
IBCL-380: Clinical Features of Non-Hodgkin Lymphomas with Primary Involvement of Peripheral Lymph Nodes in an Elderly Population
2020
·
Victor Tomacinschii
, Maria Robu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Real-World Outcomes and Morphological Patterns of Aggressive Non-Hodgkin Lymphoma in Moldova: A Five-Year Retrospective Cohort Study
2026
·
Artur ANTOSEL
, Cristina DUDNIC
, et al.
·
Documenta Haematologica - Revista Romana de Hematologie
PDF
Contemporary insights into diagnosis and treatment of gastrointestinal non-Hodgkin lymphomas
2026
·
Larisa Musteata
, Maria Robu
, et al.
·
Moldovan Journal of Health Sciences
PDF
Etiological, Clinical, Diagnostic, and Treatment Particularities of Primary Aggressive Bone Lymphoma
2025
·
Dumitrita URESCU
, Vasile MUSTEATA
, et al.
·
Documenta Haematologica - Revista Romana de Hematologie
PDF
Cardiac Dysfunction in Non-Hodgkin Lymphomas: The Influence of Comorbidities and Cardiovascular Risk Factors
2025
·
Daniela Bursacovschi
, Valeriu Revenco
, et al.
·
Bulletin of the Academy of Sciences of Moldova Medical Sciences
PDF
Diastolic Function and Cancer Therapy-related Cardiac Dysfunction in Non-hodgkin Lymphoma Patients
2025
·
Daniela BURSACOVSCHI
, Valeriu REVENCO
, et al.
·
Archives of the Balkan Medical Union
PDF
Antiphospholipid Antibodies in Non-Hodgkin's Lymphoma
2025
·
Sanda BURUIANA
, Maria ROBU
, et al.
·
Documenta Haematologica - Revista Romana de Hematologie
PDF
Evolution of Cardiopulmonary Functional Capacity in Non-hodgkin Lymphoma Patients Undergoing Antitumoural Treatment
2024
·
Daniela BURSACOVSCHI
, Valeriu REVENCO
, et al.
·
Archives of the Balkan Medical Union
PDF
POSTER: MPN-380 Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
2023
·
Nina Sghibneva-Bobeico
, Vasile Musteata
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MPN-380 Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
2023
·
Nina Sghibneva-Bobeico
, Vasile Musteata
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Pb2364: Demographics, Pattern of Care, and Outcomes of Primary Nodal Peripheral T-cell Lymphomas. Data From the Moldovan Hematological Center.
2023
·
Victor Tomacinschii
, Maria Robu
, et al.
·
HemaSphere
Diagnosis and Treatment of Autoimmune Thrombocytopenia
2023
·
Taralunga Victoria
, Robu Maria
·
Zenodo (CERN European Organization for Nuclear Research)
The Global Well-being of Patients With Non-hodgkin Lymphomas
2023
·
"
, Sanda BURUIANA
, et al.
·
Archives of the Balkan Medical Union
PDF
Show more works
View as search
Works count:
39
Citation count:
31
H-index:
3
I10-index:
Year
Topic
Type